Silent versus cranial giant cell arteritis. Initial presentation and outcome of 50 biopsy-proven cases

European Journal of Internal Medicine

Volumn 16, Issue 3, 2005, Pages 183-186

  Hamidou, Mohamed A ^a   Batard, Eric ^a   Trewick, David ^a   Masseau, Agathe ^a   Moreau, Anne ^a   Agard, Christian ^a   Ponge, Thierry ^a   Grolleau, Jean Yves ^a   Barrier, Jacques ^a  

^a HÔTEL DIEU   (France)

Author keywords

Fever of unknown origin; Giant cell arteritis; Systemic inflammatory response

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CORTICOSTEROID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTHRALGIA; ARTICLE; BIOPSY; BLINDNESS; BLOOD VESSEL BIOPSY; CHRONIC INFLAMMATION; CLAUDICATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; GIANT CELL ARTERITIS; HEADACHE; HOSPITAL DEPARTMENT; HUMAN; JAW DISEASE; MALE; OUTCOMES RESEARCH; PREVALENCE; PYREXIA IDIOPATHICA; RELAPSE; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SYMPTOMATOLOGY; TEMPORAL ARTERITIS; TEMPORAL ARTERY; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

EID: 20444506350     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.02.001     Document Type: Article

References (21)

1. E.B.V. Machado, C.J. Michet, D.J. Ballard, G.G. Hunder, C.M. Beard, and C.P. Chu Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985 Arthritis Rheum 31 1988 745 749
2. C. Salvarani, F. Cantini, L. Boiardi, and G.G. Hunder Polymyalgia rheumatica and giant-cell arteritis N Engl J Med 347 2002 261 271
3. C.M. Weyand, and J.J. Goronzy Giant-cell arteritis and polymyalgia rheumatica Ann Intern Med 139 2003 505 515
4. K.T. Calamia, and G.G. Hunder Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin Arthritis Rheum 24 1981 1414 1418
5. B.E. Malvalm, B.A. Bengtsson, K. Alestig, G. Bojs, and S. Iwarson The clinical pictures of giant cell arteritis: temporal arteritis, polymyalgia rheumatica and fever of unknown origin Postgrad Med J 67 1980 141 148
6. D.C. Knockaert, L.J. Vanneste, and H.J. Bobbaers Fever of unknown origin in elderly patients J Am Geriatr Soc 41 1993 1187 1192
7. G.D. Desmet, D.C. Knockaert, and H.J. Bobbaers Temporal arteritis: the silent presentation and delay in diagnosis J Intern Med 227 1990 237 240
8. E. Liozon, F. Boutros-Toni, K. Ly, V. Loustaud-Ratti, P. Soria, and E. Vidal Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short-term course J Rheumatol 30 2003 1272 1276
9. M.A. Gonzalez-Gay, C. Garcia-Porrua, J.C. Amor-Dorado, and J. Llorca Giant cell arteritis without clinically evident vascular involvement in a defined population Arthritis Rheum 51 2004 274 277
10. G.G. Hunder, D.A. Bloch, B.A. Michel, M.B. Stevens, W.P. Arend, and L.H. Calabrese The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis Arthritis Rheum 33 1990 1122 1128
11. J.C. Jennette, R.J. Falk, K. Andrassy, P.A. Bacon, J. Churg, and W.L. Gross Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 1994 187 192
12. P. Chevalet, J.H. Barrier, P. Pottier, G. Magadur-Joly, M.A. Pottier, and M. Hamidou A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year follow up study of 164 patients J Rheumatol 27 2000 1484 1491
13. M.C. Cid, C. Font, J. Oristrell, A. de la Sierra, B. Coll-Vinent, and A. Lopez-Soto Association between strong inflammatory response and low risk of developing visual loss and other cranial complications in giant cell (temporal) arteritis Arthritis Rheum 41 1998 26 32
14. M.A. Gonzalez-Gay, C. Garcia-Porrua, J. Llorca, A.H. Hajeer, F. Branas, and A. Dababneh Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients Medicine 79 2000 283 292
15. E. Liozon, F. Herrmann, K. Ly, P.Y. Robert, V. Loustaud, and P. Soria Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients Am J Med 111 2001 211 217
16. M.C. Cid, J. Hernandez-Rodriguez, M.J. Esteban, M. Cebrian, Y.S. Gho, and C. Font Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis Circulation 106 2002 1664 1671
17. J. Hernandez-Rodriguez, M. Segarra, C. Vilardell, M. Sanchez, A. Garcia-Martinez, and M.J. Esteban Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis. Angiogenic activity of interleukin-6 as a potential protective mechanism Circulation 107 2003 2428 2434
18. J. Hernandez-Rodriguez, A. Garcia-Martinez, J. Casademont, X. Filella, M.J. Esteban, and A. Lopez-Soto A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant cell arteritis Arthritis Rheum 47 2002 29 35
19. G. Nesher, Y. Berkun, M. Mates, M. Baras, R. Nesher, and A. Rubinow M. Risk factors for cranial ischemic complications in giant cell arteritis Medicine 83 2004 114 122
20. M.A. Gonzalez-Gay, C. Garcia-Porrua, J.C. Amor-Dorado, and J. Llorca Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population Arthritis Rheum 51 2004 652 655
21. A. Proven, S.E. Gabriel, C. Orces, W.M. O'Fallon, and G.G. Hunder Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes Arthritis Rheum 49 2003 703 708